Skip to content

The effect of salvia officinalis vaginal cream on vaginitis in diabetic women

Comparison of Salvia Officinalis vaginal cream and clotrimazole in the treatment of vaginal candidiasis in Diabetes women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190221042787N1
Enrollment
68
Registered
2019-05-12
Start date
2019-04-09
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal candidiasis Diabetes women. Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: Salvia Officinalis Vaginal Cream 2% ,an applicator every night for 7 nights. Intervention 2: Control group: clotrimazole vaginal cream1% ,an applicator every night

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Written consent for participation in the study Have at least reading and writing skills Resident of Mashhad city Married and having more than 15 years of ages Prove diabetes by examining a patient's case No history of clotrimazole susceptibility No history of allergy to the lamina family No pregnancy Non-Lactation Lack of menopause No IUD and Not using hormonal contraceptive methods Non-use of special medication within the last two weeks Failure to catch vaginal candida infection more than 4 times a year Lack of a menstrual period or any vaginal bleeding Having a score of at least 3 of the total score of symptoms and symptoms of vaginal candida infection during examination and observation In the examination of the absence of genital tract infections Positive vaginal discharge culture of a candidate Not having a medical condition other than diabetes Lack of acute and new stress in the last 8 weeks No addiction or hookah smoking Having a single partner Failure to perform curettage,Histro Salpango Graphy? surgery in the last two weeks Not getting blood and Chemotherapy in the last 4 weeks No use of antifungals to treat Vaginal infection in the last two weeks Not having sexually transmitted infections in the last month

Exclusion criteria

Exclusion criteria: Refusal to participate in research by research unit Having sensitivity to the medicine given Having acute and severe stress during treatment Use of certain medication during treatment The use of an anti fungal drug with a given drug period monthly or abnormal bleeding during the study Lack of vaginal cream over one night Antibiotic therapy during treatment Use of aromatic and sanitary materials for washing the vagina Use of herbal remedy or other anti fungal medication (topical or oral) with the medicine given

Design outcomes

Primary

MeasureTime frame
Vaginal Candidiasis in Diabetes Women. Timepoint: A week± 24 hours. Method of measurement: Culture Discharg In laboratory.

Secondary

MeasureTime frame
Itching. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: Patient's biography.;Erythema. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: Clinical examination, observation and patient history.;Irritation. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: patient history.;Painful intercourse. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: patient history.;The result of vaginal discharge culture. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: vaginal discharge culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRaha Pirouzmand

Mashhad University of Medical Sciences

pirouzmandr961@mums.ac.ir+98 51 3732 4050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026